Black Diamond Therapeutics Inc Sustainability Reports
Black Diamond Therapeutics, Inc. is a clinical-stage precision oncology medicine company. It focuses on discovering and developing small molecule, tumor-agnostic therapies that target undrugged families of oncogenic mutations.
Sector: Professional & technical services
Country: United States
Exchange: Nasdaq
FIGI: BBG00MS4Y0X8
3 reports from 2023 to 2025
